Day Fiona L, Sherwood Emma, Chen Tina Y, Barbouttis Margaret, Varlow Megan, Martin Jarad, Weber Marianne, Sitas Freddy, Paul Christine
Department of Medical Oncology, Calvary Mater Newcastle, Waratah, NSW, Australia.
School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.
Asia Pac J Clin Oncol. 2018 Dec;14(6):431-438. doi: 10.1111/ajco.12876. Epub 2018 Apr 29.
Continued smoking in patients diagnosed with cancer affects treatment outcomes and overall survival. With national surveys of Australian medical oncologists (MO) and radiation oncologists (RO) we sought to determine current clinical practices, preferences and barriers in providing patient smoking cessation support.
Oncologist members of the Medical Oncology Group of Australia (n = 452) and Trans-Tasman Radiation Oncology Group (n = 230) were invited to participate in a multiple choice survey exploring smoking cessation practices and beliefs.
The survey response rate was 43%. At first consultations more than 90% of MO and RO regularly asked patients if they smoke or use tobacco products, closely followed by documentation of duration of smoking history and current level of consumption. Less common was asking the patient if they intended to quit (MO 63%, RO 53%) and advising cessation (MO 70%, RO 72%). Less than 50% of oncologists regularly asked about current smoking in follow-up consultations. Although a range of referral options for smoking cessation care were used by oncologists, only 2% of MO and 3% of RO actively managed the patients' smoking cessation themselves and this was the least preferred option. The majority believed they require more training in cessation interventions (67% MO, 57% RO) and cited multiple additional barriers to providing cessation care.
Oncologists strongly prefer smoking cessation interventions to be managed by other health workers. A collaborative approach with other health professionals is needed to aid the provision of comprehensive smoking cessation care tailored to patients with cancer.
确诊为癌症的患者持续吸烟会影响治疗效果和总生存期。通过对澳大利亚医学肿瘤学家(MO)和放射肿瘤学家(RO)进行全国性调查,我们试图确定在为患者提供戒烟支持方面的当前临床实践、偏好和障碍。
邀请澳大利亚医学肿瘤学组(n = 452)和跨塔斯曼放射肿瘤学组(n = 230)的肿瘤学家成员参与一项多项选择调查,以探究戒烟实践和信念。
调查回复率为43%。在初次会诊时,超过90%的医学肿瘤学家和放射肿瘤学家会定期询问患者是否吸烟或使用烟草制品,紧随其后的是记录吸烟史时长和当前吸烟量。较少询问患者是否打算戒烟(医学肿瘤学家为63%,放射肿瘤学家为53%)以及建议戒烟(医学肿瘤学家为70%,放射肿瘤学家为72%)。不到50%的肿瘤学家在后续会诊中会定期询问患者当前的吸烟情况。尽管肿瘤学家使用了一系列戒烟护理的转诊选项,但只有2%的医学肿瘤学家和3%的放射肿瘤学家会主动亲自管理患者的戒烟事宜,而这是最不受欢迎的选项。大多数人认为他们需要更多关于戒烟干预的培训(67%的医学肿瘤学家,57%的放射肿瘤学家),并列举了提供戒烟护理的多个其他障碍。
肿瘤学家强烈倾向于由其他医护人员管理戒烟干预措施。需要与其他健康专业人员采取协作方法,以帮助提供针对癌症患者的全面戒烟护理。